Skip to main content
. 2023 Jun 27;11(7):1167. doi: 10.3390/vaccines11071167

Table 2.

Baseline clinical characteristics for participants stratified by mpox vaccination status.

Clinical Characteristics Unvaccinated
(n = 489)
Vaccinated
(n = 238)
p-Value aOR [95% Confidence Interval]
Age (years) 56.9 (48.6–64.6) 53.8 54 (48.0–59.6) <0.001 0.9 [0.9–1.0]
Alcohol (units per week) 7 (2–15) 6 (1.2–13) 0.3 1.0 [0.9–1.0]
Alcohol (more than 10 unit per week) 175 (36% [32–40%]) 81 (34% [28–40%]) 0.7 1.0 [0.7–1.4]
Smoking status 0.01
 Ex-smoker 178 (36% [32–41%]) 85 (36% [30–42%]) 0.9 [0.6–1.4]
 Never smoked 153 (31% [27–36%]) 95 (40% [34–46%]) 1.7 [1.2–2.6]
 Current smoker 153 (31% [27–36%]) 52 (22% [17–28%]) 0.6 [0.4–0.9]
Origin 0.3
 Scandinavian 378 (77% [73–81%]) 189 (79% [74–84%]) 1.5 [0.9–2.6]
 Other European 61 (12% [10–16%]) 22 (9% [6–14%]) 1.1 [0.5–2.2]
 Other 60 (12% [9–16%]) 27 (11% [8–16%]) 0.7 [0.4–1.2]
Plasma HIV RNA < 50 copies/mL 464 (94% [93–96.6%]) 222 (93% [89–96%]) 0.5 0.7 [0.4–1.4]
Blood CD4+ lymphocyte count, cells/µL 691.3 (253) 702.6 (276.2) 1.0 [1.0–1.0]
Education 0.3
 No education or a short education 227 (46% [42–51%]) 102 (43% [36–49%]) 0.9 [0.6–1.2]
 Long education 239 (49% [44–53%]) 128 (54% [47–60%]) Model did not converge
STD in the preceding two years 85 (17% [14–21%]) 99 (42% [35–48%]) <0.001 3.1 [2.2–4.6]

STD: sexually transmitted disease.